Compare Lucid Group Inc (LCID) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lucid Group Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Lucid Group Inc trades at $3.26 (market cap $1.30B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 3.9× Lucid Group Inc's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lucid Group Inc for 45 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| LCID | ORKA | |
|---|---|---|
Market Cap | $1.30B | $5.08B |
Volume | 16,941,666 | 685,276 |
Sector | Consumer Cyclical | Health |
52-Week High | $21.67 | $113.08 |
52-Week Low | $3.29 | $26.19 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $4.19B | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lucid Group (LCID) trades at $3.36, down 2.33% with a bearish technical signal despite some oversold RSI readings. The company shows severe financial stress with negative gross profit margin of -96.56% and net income margin of -249.21%, missing earnings expectations for three consecutive quarters. Recent news highlights management's focus on $1.4 billion cost savings and strategic partnerships for autonomous vehicle deployment in Europe.
The outlook remains challenging with persistent cash burn and delayed product launches creating significant execution risk. While analyst consensus suggests 109% upside to the $7.00 price target, the high concentration of hold ratings (67%) reflects caution about Lucid's ability to achieve profitability amid intense EV competition.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
